OBJECTIVE: To assess relations of left ventricular (LV) geometry and function to insulin resistance in obesity ± a condition associated with volume overload and abnormal LV relaxation. DESIGN: Cross-sectional relational study. SUBJECTS: 27 healthy overweight±obese subjects (18 women, body mass index (BMI) 35.0 AE 4.0 kgam 2 ) and 31 agematched normal-weight controls (21 women, BMI 22.6 AE 2.4 kgam 2 ). MEASUREMENTS: Subjects were studied by Doppler-echocardiography the same day and hour (08.00 h) as measurements of fasting insulin and blood glucose were made. Insulin resistance was determined by the`Homeostasis Assessment Model'. RESULTS: Twelve obese subjects with insulin resistance (IR) had higher body size than 15 patients without IR and higher blood pressure than normal-weight controls (all P`0.01). Relative IR was related to isovolumic relaxation time. This relation was not maintained after controlling for age, blood pressure, weight and height. Isovolumic relaxation time was, however, positively related to diastolic blood pressure, a measure of load, in normal controls (r 0.44) and obese without IR (r 0.62) but not in insulin resistant subjects (r 0.14). CONCLUSION: IR does not independently in¯uence myocardial relaxation in uncomplicated obesity, but modulates the effect of load on active diastole.
Introduction
Precocious diastolic dysfunction has been recently reported in uncomplicated obesity, characterised by prolongation of left ventricular (LV) relaxation, the active phase of diastole. 1, 2 Since no demographic or haemodynamic causes could be identi®ed to explain this abnormality, 2 an impairment of the process of inactivation of actin-myosin cross-bridges has been suggested to play a direct role, addressing the possibility that metabolic abnormalities might be at least in part involved in the alteration of the active diastolic phase in obese subjects. The process of inactivation is based on the active, energy-consuming re-uptake of Ca ions from the cytosol to the sarcoplasmic reticulum 3 and there is clear evidence that insulin in¯uences the activity of a number of membrane pumps, including Na aK , Na aCa and Ca aMg pumps. 4±6 A condition of resistance to the peripheral effects of the hormone, might lead to a lower Ca re-uptake during the ®rst diastolic phase, resulting in prolonged isovolumic relaxation. Because hyperinsulinaemia and insulin resistance (IR) are characteristics of obesity, 7±10 we tested the hypothesis that the process of myocardial inactivation (and thus active relaxation) is affected by abnormal peripheral activity of the hormone. Accordingly, this study was designed to assess the relation of LV systolic and diastolic function and geometry to IR in uncomplicated obesity.
Methods

Study population
Twenty-seven otherwise normal overweight±obese subjects (18 women 2 ) and normal IR, were not classi®ed for the subgroup analysis and were excluded from the study.
Procedures
Eligible individuals underwent fasting blood collection at 08.00 h to determine both plasma insulin and glucose, on the same day as a complete Dopplerechocardiographic study was performed.
IR was estimated from fasting plasma insulin and glucose using the`Homeostasis Model Assessment (HOMA)', 13 a computer-solved model of glucosea insulin interactions, that predicts IR from fasting plasma glucose and insulin level. 14 The use of this model for the evaluation of IR has been validated by comparison with the hyperinsulinaemic euglycaemic clamp technique. 15 Blood pressure was measured after echocardiography in the supine position, using an arm-cuff of appropriate size and a mercury sphygmomanometer. Coronary artery disease was excluded in all the participants on the basis of the absence of symptoms, a negative WHO questionnaire on angina and myocardial infarction and a clinical examination (including 12-lead ECG).
Echocardiography
Echocardiograms were recorded by expert sonographers with the subjects in partial left decubitus position using a commercially available machine (SIM 7000 CFM Challenge, Esaote Biomedica, Florence, Italy) equipped with a 2.5±3.5 MHz annular-array transducer. M-Mode tracings were obtained from the parasternal LV short axis view, recorded on video-tape, printed-out on strip-chart paper at 50 cmas velocity and read by two blinded observers, according to the standard of our laboratory. 2, 16 LV chamber dimensions, septum and posterior wall thickness were measured according to the American Society of Echocardiography. 17 The Penn Convention was also used only to calculate LV mass. 18 LV mass was therefore normalised for height to the 2.7 power, 19 a method that has been shown to take into account the independent effect of obesity on LV geometry. Relative wall thickness was used as a measure of concentric geometry and calculated as posterior wall thickness, divided by left ventricular end-diastolic radius. 2, 20 Systolic shortening of the left ventricle was evaluated at midwall level and used as a measure of LV performance. 21 Myocardial afterload was evaluated as circumferential end-systolic stress, based on a cylindrical model, as previously reported. 21 LV isovolumic relaxation time and diastolic ®lling velocities were obtained, respectively, from the apical ®ve and four chamber view. Transmitral¯ow velocity was obtained by Pulsed-Wave Doppler interrogation of the LV in¯ow tract, with the sample volume placed at the tips of the mitral valve and peak early diastolic ow velocity (E), peak late diastolic¯ow velocity (A) and deceleration time of early¯ow velocity were measured. Atrial ®lling fraction was calculated as previously reported. 2 Isovolumic relaxation time was calculated as the interval between the end of aortic ow and the onset of mitral¯ow recorded in an apical ®ve chamber view with the sample volume placed between LV out¯ow tract and the anterior mitral lea¯et.
2 Doppler signals were recorded at high speed on videotape, with the patient in held expiration and measured using electronic calipers. The average of ®ve beats was used for the analysis.
Statistical analysis
Variables were expressed as mean AE 1 s.d. Since distribution of some variables was skewed, data were logarithmically transformed for analysis with parametric procedures.
One-factor analysis of variance was used to compare measures of LV geometry, relaxation and ®lling. The step-down multiple stage F post-hoc test (Ryan, Elliot, Gabriel and Welchs or REGW F-test) was used for multiple comparison.
Analysis of covariance was used to control the between-group difference of LV geometry for the effect of age and gender, and differences in isovolumic relaxation time for the effect of blood pressure, LV mass and LV end-diastolic diameter.
The null hypothesis was rejected at a two-tailed P 0.05.
Results
As expected, the plasma insulin concentration was higher in obese subjects (13.4 AE 4.7 maUaml) than in normal-weight controls (8.4 AE 2.2 mUaml; P`0.0001). The index of IR, as assessed by homeostasis assessment model, was markedly higher in obese (2.8 AE 4.2) vs normal-weight control group (1.6 AE 0.6; P`0.0001). Table 1 shows general characteristics of the study groups: the degree of obesity was signi®cantly more severe in patients with IR (P`0.002 vs obese without IR), who also exhibited higher blood pressure (P`0.01) and plasma glucose (P`0.05) than normal-weight controls. Heart rate was similar among groups.
LV geometry and systolic function (Table 2) The LV diastolic dimension was comparable among groups, whereas the left atrium was larger in obese, than in normal-weight, individuals (all P`0.001). LV mass index was higher in both obese groups than in normal-weight individuals (P`0.001), differences that remained after adjusting for age and gender. Relative wall thickness was also higher in obese subjects with IR than in those with normal insulinsensitivity (P`0.02) and in normal-weight subjects (P`0.001) after adjusting for age and gender (both P`0.001).
Midwall shortening was slightly lower in both obese groups than in normal-weight controls (P`0.01, independently of IR, whereas myocardial afterload (as expressed by circumferential end-systolic stress) was not signi®cantly different among groups.
LV diastolic relaxation and ®lling (Table 3) Isovolumic relaxation time was similarly prolonged in both groups of obese subjects compared to the normal-weight group (both P`0.001), independently of the effect of age and gender, without any signi®cant difference between patients with or without IR. Even after controlling for the effect of blood pressure and LV mass by the analysis of covariance, isovolumic relaxation time was still similarly prolonged in obese subjects with normal insulin sensitivity (adjusted Cardiac effect of insulin in obesity GF Mureddu et al mean 90 msec) and in those with IR (adjusted mean 92 msec) compared to normal-weight subjects (adjusted mean 70 msec; both P`0.0001).
In normal-weight subjects, isovolumic relaxation time was positively related to diastolic blood pressure, used as a crude measure of afterload 2, 21 (P`0.02, Figure 1 ) and a similar relation was also found in obese individuals (P`0.02, Figure 2 ). However, in the obese group, this relation was only signi®cant for the obese individuals with normal insulin-sensitivity (P`0.02, Figure 2) , it was statistically negligible in insulin-resistant obese patients (Figure 2) .
LV ®lling was only marginally altered in obese patients, but late transmitral peak¯ow velocity (A) was higher in the insulin-resistant obese group than in both obese individuals without IR and normal-weight controls, consistent with the reported left atrial enlargement and the marginally higher value of relative wall thickness (Table 2) . Accordingly, the difference in peak late¯ow velocities was signi®cantly reduced when the effect of relative wall thickness was taken into account by the analysis of covariance (adjusted mean -54 cmasec in normal-weight, 51 cmasec in obese subjects without insulin resistance and 57 cmasec in obese subjects with IR). Deceleration time of early transmitral¯ow velocity was slightly longer in obese subjects without IR than in normal-weight controls (Table 3) but this difference also disappeared after further control for correlated confounders (blood pressure and heart rate; adjusted mean 139 cmasec in normal-weight, 155 cmasec in obese non insulin resistant and 147 cmasec in obese insulin resistant; P NS).
After control for age and gender, the ratio between early and late¯ow velocities and the percentage of LV ®lling due to atrial contraction were not statistically different among groups. 
Discussion
Impairment of LV active relaxation in obesity was ®rst described by Stoddard et al 1 and recently reported from our laboratory. 2 Our study showed that isovolumic relaxation time was primarily prolonged in young otherwise-healthy obese subjects independent of the effect of age, gender, blood pressure, LV geometry and load, suggesting that impairment of relaxation could be due to alteration of inactivation by itself, a process that is regulated by metabolic status. 3, 22 Inactivaton of actin-myosin cross-links is an energy-consuming process, consequent to calciumion re-uptake by the sarcoplasmic reticulum. It represents the biochemical basis of diastolic relaxation. 3, 22 Because insulin in¯uences the activity of both the Na /K and the Na /Mg membrane ATP-ase, 4±6 we developed the hypothesis that the process of myocardial inactivation could be affected by the abnormal activity of peripheral insulin in obese subjects. In fact, in physiological conditions, insulin may determine hyperpolarization of muscle ®bres through at least two mechanisms: (1) by activating the Na /K ATP-ase on the plasma membrane and promoting increased Na aCA exchange with a consequent reduction of intracellular calcium concentration 4, 5 and (2) by enhancing the Ca re-uptake from the sarcoplasmic reticulum through a direct stimulation of the Ca aMg pump. 6 An impairment of one or both these processes may lead to higher intracellular Ca levels during diastole, prolonging relaxation.
3,22±24
The haemodynamic consequence of IR is well studied in obesity, as well as in arterial hypertension, 7±10,25±29 and is closely linked with the above biological activities. In this study, isovolumic relaxation time was similarly prolonged in non insulin resistant and insulin resistant obese patients, suggesting that either insulin action does not play a role in the mechanism of inactivation, or the alteration of relaxation in the two groups has different mechanisms. Findings from this study suggest that different mechanisms may indeed be involved in the prolongation of LV active relaxation in obesity. Cardiac load is one of the factors controlling LV relaxation, 22,30±33 nevertheless, the ability of loading conditions to prolong relaxation is blunted when primary impairment of inactivation occurs. 22, 32, 33 Because high levels of plasma Ca make relaxation independent of load, 33 a dysfunction of the insulin-mediated Ca mechanism might be more important than cardiac load in insulinresistant obese individuals. The lack of relation between isovolumic relaxation time and diastolic pressure (a type of contraction load) in obese subjects with IR, suggests indeed that inactivation-dependent impairment of relaxation might predominate over load-dependent mechanisms. In contrast, in obese subjects with normal insulin activity, as well as in normal controls, the process of inactivation is probably normal and relaxation is more dependent on loading conditions, 30, 31 as the positive relation with diastolic pressure demonstrates.
In apparent contrast with ®ndings by Sasson et al, 34 no evidence of independent correlation between IR and LV mass was observed in these study-groups, because the relation between relative IR and LV geometry was largely in¯uenced by age and gender. Moreover, the relation between LV wall thickness and IR described by some authors, 35 was largely due to the glucose disposal rate during the clamp procedure, than to the degree of fasting hyperinsulinaemia.
Conclusions
Our results suggest that there is a balance between metabolic and load-dependent factors controlling LV relaxation in obesity. Values of isovolumic relaxation time are similar in obese subjects with IR and in those with normal insulin activity, because of a different balance between the in¯uences of the inactivation process (more important in insulin-resistant patients) and the loading conditions (more prominent in the non insulin resistant individuals, as well as in normal conditions).
